The present invention relates to novel drug targets for pathogenic
bacteria. Accordingly, the invention provides purified protein derived
from Fransicella tularensis comprising the amino acid sequence set forth
in SEQ ID NO: 2. The invention also provides biochemical and biophysical
characteristics of the polypeptides of the invention.